This patient had extreme hypertriglyceridemia (HTG; TG level >1000 mg/dL)—indicated by milky plasma—combined with new abdominal pain and multiple acquired risk amplifiers (T2DM, heavy alcohol use, and a thiazide diuretic). According to risk data, the annualized incidence of acute pancreatitis rises to 1.21% at TG level >1000 mg/dL and up to 29.98% in those with prior events. Given his abdominal symptoms, emergent evaluation would be the priority.
Statins are not effective for severely elevated TG levels and do not address the acute pancreatitis risk. They are useful for ASCVD risk reduction (relevant at TG levels 150-499 mg/dL); however, in acute, extreme HTG, the immediate goal is TG level reduction and safety assessment, not long-term LDL-C level lowering.
Although apo B and ASCVD risk scoring are important in moderate HTG, he had secondary concerns. LDL-C levels cannot be calculated at TG levels >400 mg/dL. The acute pancreatitis risk from extreme TG level elevation takes precedence over ASCVD risk stratification.
Fibrates are first-line pharmacotherapy for TG levels ≥500 mg/dL, but initiating a fibrate and waiting 6 weeks would not be appropriate when a patient has TG levels >1000 mg/dL with abdominal pain. Lifestyle intervention (alcohol cessation, extreme fat restriction) and urgent evaluation must occur first. Secondary drivers (e.g., thiazide diuretic use, uncontrolled T2DM) should be addressed concurrently.
This patient case quiz is part of the larger Hypertriglyceridemia (HTG) and Cardiovascular (CV) Health: Recognizing Risks and Tackling Management initiative, supported by Ionis Pharmaceuticals. To visit the HTG and CV Health grant page and access additional educational activities on this topic, click here.
References
- Sanchez RJ, Ge W, Wei W, Ponda MP, Rosenson RS. The association of triglyceride levels with the incidence of initial and recurrent acute pancreatitis. Lipids Health Dis. 2021;20(1):72. Published 2021 Jul 18. doi:10.1186/s12944-021-01488-8
- Carr RA, Rejowski BJ, Cote GA, Pitt HA, Zyromski NJ. Systematic review of hypertriglyceridemia-induced acute pancreatitis: a more virulent etiology?. Pancreatology. 2016;16(4):469-476. doi:10.1016/j.pan.2016.02.011
- Berglund L, Brunzell JD, Goldberg AC, et al. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012;97(9):2969-2989. doi:10.1210/jc.2011-3213
- Grundy SM, Stone NJ, Bailey AL, et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2019;73(24):e285-e350. doi:10.1016/j.jacc.2018.11.003
